Provider preferences for resolving uncertainty and avoiding harms in precision medicine: a discrete choice experiment.

Substantial uncertainty exists about how providers assess the value of genomic testing. We developed and administered a discrete choice experiment to a national sample of providers. We analyzed responses using an error components mixed logit model.